Virus safety evaluation of biotechnological investigational medicinal products - Scientific guideline

This document provides scientific guidance on the viral safety of biotechnological medicinal products used in clinical trials.

Keywords: Virus safety, clinical trial, investigational medicinal products (IMPs)

Current effective version

Guideline on virus safety evaluation of biotechnological investigational medicinal products

AdoptedLegal effective date: 01/02/2009Reference Number: EMEA/CHMP/BWP/398498/2005

English (EN) (71.62 KB - PDF)

First published: 24/07/2008Last updated: 24/07/2008

Overview of comments received on draft guideline on virus safety evaluation of biotechnological investigational medicinal products

Reference Number: EMEA/CHMP/BWP/67410/2007

English (EN) (320.89 KB - PDF)

First published: 17/09/2008Last updated: 17/09/2008

Draft guideline on virus safety evaluation of biotechnological investigational medicinal products

Draft: consultation closedReference Number: EMEA/CHMP/BWP/398498/2005-corr

English (EN) (101.45 KB - PDF)

First published: 28/06/2006Last updated: 28/06/2006

Concept paper on the development of a guideline on viral safety evaluation of biotechnological products to be used in clinical trials

Reference Number: EMEA/CHMP/BWP/124447/2004

English (EN) (144.59 KB - PDF)

First published: 15/12/2004Last updated: 15/12/2004